Epicardial adipose tissue is associated with extent of pneumonia and adverse outcomes in patients with COVID-19

[1]  D. Dey,et al.  Quantitative Burden of COVID-19 Pneumonia on Chest CT Predicts Adverse Outcomes: A Post-Hoc Analysis of a Prospective International Registry , 2020, Radiology. Cardiothoracic imaging.

[2]  F. Sardanelli,et al.  Epicardial Fat Inflammation in Severe COVID‐19 , 2020, Obesity.

[3]  Mikiko Watanabe,et al.  Is Growth Hormone Insufficiency the Missing Link Between Obesity, Male Gender, Age, and COVID‐19 Severity? , 2020, Obesity.

[4]  L. Strigari,et al.  Visceral fat shows the strongest association with the need of intensive care in patients with COVID-19 , 2020, Metabolism.

[5]  B. Hamm,et al.  The role of visceral adiposity in the severity of COVID-19: Highlights from a unicenter cross-sectional pilot study in Germany , 2020, Metabolism.

[6]  K. Khunti,et al.  Body mass index and the risk of COVID‐19 across ethnic groups: Analysis of UK Biobank , 2020, Diabetes, obesity & metabolism.

[7]  M. Massari,et al.  Tocilizumab in patients with severe COVID-19: a retrospective cohort study , 2020, The Lancet Rheumatology.

[8]  Jennifer L. Bell,et al.  Effect of Dexamethasone in Hospitalized Patients with COVID-19: Preliminary Report , 2020, medRxiv.

[9]  Seongwook Han,et al.  Epicardial adipose tissue: fuel for COVID-19-induced cardiac injury? , 2020, European heart journal.

[10]  J. Goldberger,et al.  Does epicardial fat contribute to COVID-19 myocardial inflammation? , 2020, European heart journal.

[11]  D. Brodie,et al.  Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study , 2020, The Lancet.

[12]  M. Rotondi,et al.  The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system , 2020, Cytokine & Growth Factor Reviews.

[13]  Norbert Stefan,et al.  Obesity and impaired metabolic health in patients with COVID-19 , 2020, Nature Reviews Endocrinology.

[14]  M. Nannipieri,et al.  Letter to the Editor: Importance of metabolic health in the era of COVID-19 , 2020, Metabolism.

[15]  A. Malavazos,et al.  Targeting the Adipose Tissue in COVID‐19 , 2020, Obesity.

[16]  S. Manfrini,et al.  Obesity and SARS‐CoV‐2: A population to safeguard , 2020, Diabetes/metabolism research and reviews.

[17]  N. Caplice,et al.  Is Adipose Tissue a Reservoir for Viral Spread, Immune Activation, and Cytokine Amplification in Coronavirus Disease 2019? , 2020, Obesity.

[18]  D. Brodie,et al.  Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study , 2020, medRxiv.

[19]  Carl H. June,et al.  Cytokine release syndrome in severe COVID-19 , 2020, Science.

[20]  Nathaniel Hupert,et al.  Clinical Characteristics of Covid-19 in New York City , 2020, The New England journal of medicine.

[21]  Nicola Sverzellati,et al.  Well-aerated Lung on Admitting Chest CT to Predict Adverse Outcome in COVID-19 Pneumonia , 2020, Radiology.

[22]  Anna Stachel,et al.  Obesity in patients younger than 60 years is a risk factor for Covid-19 hospital admission , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  D. Mathieu,et al.  High Prevalence of Obesity in Severe Acute Respiratory Syndrome Coronavirus‐2 (SARS‐CoV‐2) Requiring Invasive Mechanical Ventilation , 2020, Obesity.

[24]  W. Dietz,et al.  Obesity and its Implications for COVID‐19 Mortality , 2020, Obesity.

[25]  Heshui Shi,et al.  Temporal Changes of CT Findings in 90 Patients with COVID-19 Pneumonia: A Longitudinal Study , 2020, Radiology.

[26]  Lei Liu,et al.  Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China , 2020, Diabetes Care.

[27]  J. Xiang,et al.  Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study , 2020, The Lancet.

[28]  Z. Fayad,et al.  Chest CT Findings in Coronavirus Disease-19 (COVID-19): Relationship to Duration of Infection , 2020, Radiology.

[29]  Yicheng Fang,et al.  Sensitivity of Chest CT for COVID-19: Comparison to RT-PCR , 2020, Radiology.

[30]  D. Dey,et al.  Deep Learning–Based Quantification of Epicardial Adipose Tissue Volume and Attenuation Predicts Major Adverse Cardiovascular Events in Asymptomatic Subjects , 2020, Circulation. Cardiovascular imaging.

[31]  S. Röhrich,et al.  Automatic lung segmentation in routine imaging is primarily a data diversity problem, not a methodology problem , 2020, European Radiology Experimental.

[32]  Ting Yu,et al.  Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study , 2020, The Lancet.

[33]  Y. Yoon,et al.  Association between thoracic fat measured using computed tomography and lung function in a population without respiratory diseases. , 2019, Journal of thoracic disease.

[34]  D. Dey,et al.  Fully Automated CT Quantification of Epicardial Adipose Tissue by Deep Learning: A Multicenter Study. , 2019, Radiology. Artificial intelligence.

[35]  D. Dey,et al.  Perivascular Adipose Tissue and Coronary Atherosclerosis: from Biology to Imaging Phenotyping , 2019, Current Atherosclerosis Reports.

[36]  David Beymer,et al.  Lung tissue characterization for emphysema differential diagnosis using deep convolutional neural networks , 2019, Medical Imaging.

[37]  A. Mahabadi,et al.  Is epicardial fat attenuation a novel marker of coronary inflammation? , 2019, Atherosclerosis.

[38]  Hans Anton Schlößer,et al.  Cytokine release syndrome , 2018, Journal of Immunotherapy for Cancer.

[39]  M. Packer.  Epicardial Adipose Tissue May Mediate Deleterious Effects of Obesity and Inflammation on the Myocardium. , 2018, Journal of the American College of Cardiology.

[40]  Xi Chen,et al.  Epicardial adipose tissue density and volume are related to subclinical atherosclerosis, inflammation and major adverse cardiac events in asymptomatic subjects. , 2017, Journal of cardiovascular computed tomography.

[41]  J. Stojanovska,et al.  Increased Epicardial Fat Volume Is Independently Associated with the Presence and Severity of Systemic Sclerosis. , 2017, Academic radiology.

[42]  H. Nathoe,et al.  Relation between cardiovascular disease risk factors and epicardial adipose tissue density on cardiac computed tomography in patients at high risk of cardiovascular events , 2017, European journal of preventive cardiology.

[43]  E. Kalaycıoğlu,et al.  Epicardial fat thickness is associated with severity of disease in patients with chronic obstructive pulmonary disease. , 2016, European review for medical and pharmacological sciences.

[44]  Zaipei Guo,et al.  Epicardial fat tissue in patients with psoriasis:a systematic review and meta-analysis , 2016, Lipids in Health and Disease.

[45]  M. Paoli,et al.  Epicardial Fat Thickness as Cardiovascular Risk Factor and Therapeutic Target in Patients with Rheumatoid Arthritis Treated with Biological and Nonbiological Therapies , 2014, Arthritis.

[46]  M. Czech,et al.  Epicardial and Perivascular Adipose Tissues and Their Influence on Cardiovascular Disease: Basic Mechanisms and Clinical Associations , 2014, Journal of the American Heart Association.

[47]  B. Celli,et al.  Epicardial Adipose Tissue in Patients with Chronic Obstructive Pulmonary Disease , 2013, PloS one.

[48]  P. Beck‐Peccoz,et al.  Epicardial fat thickness significantly decreases after short-term growth hormone (GH) replacement therapy in adults with GH deficiency. , 2013, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[49]  C. Burchfiel,et al.  Pericardial fat is associated with impaired lung function and a restrictive lung pattern in adults: the Jackson Heart Study. , 2011, Chest.

[50]  S. Abbara,et al.  Increased epicardial adipose tissue volume in HIV-infected men and relationships to body composition and metabolic parameters , 2010, AIDS.

[51]  N. Müller,et al.  Fleischner Society: glossary of terms for thoracic imaging. , 2008, Radiology.

[52]  Udo Hoffmann,et al.  Pericardial Fat, Visceral Abdominal Fat, Cardiovascular Disease Risk Factors, and Vascular Calcification in a Community-Based Sample: The Framingham Heart Study , 2008, Circulation.

[53]  Domenico Corradi,et al.  Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart , 2005, Nature Clinical Practice Cardiovascular Medicine.

[54]  Nigel M Hooper,et al.  ACE2: from vasopeptidase to SARS virus receptor , 2004, Trends in Pharmacological Sciences.